Cellebrite DI Ltd.
CLBT
$13.18
$0.010.08%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | -150.95M | -194.24M | -283.01M | |
| Total Depreciation and Amortization | -- | 10.57M | 10.56M | 10.61M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | 247.60M | 284.48M | 362.52M | |
| Change in Net Operating Assets | -- | 53.85M | 42.21M | 42.05M | |
| Cash from Operations | -- | 161.08M | 143.01M | 132.17M | |
| Capital Expenditure | -- | -10.95M | -9.41M | -8.57M | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -2.75M | -2.75M | -2.75M | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -106.85M | -182.22M | -138.16M | |
| Cash from Investing | -- | -120.54M | -194.38M | -149.47M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | 29.72M | 19.21M | 20.66M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -11.00K | -11.00K | -11.00K | |
| Cash from Financing | -- | 29.70M | 19.20M | 20.65M | |
| Foreign Exchange rate Adjustments | -- | 2.03M | 215.00K | -1.21M | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | 72.27M | -31.96M | 2.14M | |